The emergence of clinically relevant babesiosis in southwestern wisconsin

Wisconsin Medical Journal

Volumn 114, Issue 4, 2015, Pages 152-157

  Kowalski, Todd J ^a   Jobe, Dean A ^b   Dolan, Emily C ^b   Kessler, Anne ^b   Lovrich, Steven D ^b   Callister, Steven M ^b  

^a Gundersen Health System   (United States)

^b GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; QUININE;

ADULT; AGED; ARTICLE; BABESIA MICROTI; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IXODES SCAPULARIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; PIROPLASMOSIS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; UNITED STATES; ANIMAL; BABESIOSIS; COMMUNICABLE DISEASES, EMERGING; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; BABESIOSIS; COMMUNICABLE DISEASES, EMERGING; FEMALE; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; WISCONSIN;

EID: 84938834641     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin North Am. 2008;22(3):469-488,viii-ix
2. Herwaldt BL, Montgomery S, Woodhall D,Bosserman EA. Babesiosis surveillance - 18 states, 2011. Morb Mortal Wkly Rep. 2012;61(27):505-509
3. Herwaldt BL, Springs FE, Roberts PP, et al. Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg. 1995;53(2):146-151
4. Iacopino V, Earnhart T. Life-threatening babesiosis in a woman from Wisconsin. Arch Intern Med. 1990;150(7):1527-1528
5. Kowalski TJ, Tata S, Berth W, Mathiason MA, Agger WA. Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme diseasehyperendemic area. Clin Infect Dis. 2010;50(4):512-520
6. Lovrich SD, Jobe DA, Kowalski TJ, Policepatil SM, Callister SM. Expansion of the midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin. J Clin Microbiol. 2011;49(11):3855-3859
7. Pfeiffer CD, Kazmierczak JJ, Davis JP. Epidemiologic features of human babesiosis in Wisconsin, 1996-2005. WMJ. 2007;106(4):191-195
8. Belongia EA, Reed KD, Mitchell PD, et al. Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. Clin Infect Dis. 2001;32(10):1434-1439
9. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol. 1996;34(3):724-727
10. Steiner FE, Pinger RR, Vann CN, et al. Infection and co-infection rates of Anaplasma phagocytophilum variants, Babesia spp., Borrelia burgdorferi, and the rickettsial endosymbiont in Ixodes scapularis (acari: Ixodidae) from sites in Indiana, Maine, Pennsylvania, and Wisconsin. J Med Entomol. 2008;45(2):289-297
11. Teal AE, Habura A, Ennis J, Keithly JS, Madison-Antenucci S. A new real-time PCR assay for improved detection of the parasite Babesia microti. J Clin Microbiol. 2012;50(3):903-908
12. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155(8):509-519
13. Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang. 2006;90(3):157-165.